Results 301 to 310 of about 1,970,077 (362)

The effects of geranylgeranyl diphosphate synthase inhibitor treatment on osteoblast biology and application in a conditioned media model of myeloma bone disease. [PDF]

Bone Rep
Muehlebach ME, Holstein SA.
europepmc   +1 more source

Differential survival outcomes in upper versus lower extremity metastatic bone disease: a retrospective comparative cohort analysis. [PDF]

J Orthop Surg Res
Chen CW, Su CC, Chen JH, Wang JL, Tseng TH, Groot OQ.   +5 more
europepmc   +1 more source

Mineral Bone Disease Prevalence and Biochemical Profile in Chronic Kidney Disease Patients Undergoing Hemodialysis. [PDF]

Cureus
George J, Bhat RS.
europepmc   +1 more source

Adipose Tissue-Derived Mediators in Multiple Myeloma: Linking Obesity to Bone Disease via Inflammatory Pathways. [PDF]

Int J Mol Sci
Stroe-Ionescu AŞ, Tǎnase AD, Rotaru I, Goanțǎ JG, Pǎtraşcu AM, Boldeanu MV, Assani MZ, Siloși I, Boldeanu L, Maria DT.   +9 more
europepmc   +1 more source